Related Experiment Video
Updated: Aug 8, 2025

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction
Published on: April 4, 2025
High-pressure balloon dilatation of primary obstructive megaureter in children: a systematic review
Liisi Ripatti1, Hanna-Reeta Viljamaa2, Anna Suihko2
1Department of Pediatric Surgery, Turku University Hospital, Savitehtaankatu 5, PL 52, 20520, Turku, Finland. liisi.ripatti@tyks.fi.
Insights
Endoscopic high-pressure balloon dilatation (HPBD) effectively treats primary obstructive megaureter (POM) in children, reducing ureteral and renal pelvis diameters. This safe first-line treatment shows promising outcomes, even in infants, though further comparative studies are needed.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
- Endourology
Background:
- Primary obstructive megaureter (POM) is a congenital condition requiring effective treatment in children.
- Endoscopic high-pressure balloon dilatation (HPBD) is an emerging minimally invasive option for POM.
- Evidence regarding HPBD effectiveness and safety, particularly in infants, requires systematic evaluation.
Approach:
- A systematic review followed PRISMA guidelines to assess literature on HPBD for pediatric POM.
- Included studies reported on HPBD's effectiveness in relieving obstruction and reducing hydroureteronephrosis.
- Complication rates and outcomes, especially in children under one year, were secondary outcomes.
Key Points:
- HPBD significantly reduced ureteral diameter (15.8mm to 8.0mm) and renal pelvis anteroposterior diameter (16.7mm to 9.7mm).
- Success rates were 71% after one HPBD and 79% after two HPBD, with a median follow-up of 3.6 years.
- Overall complication rate was 33%, with no severe (Clavien-Dindo IV-V) complications; postoperative infections (12%) and VUR (7.8%) were noted. Outcomes in infants appeared similar to older children.
Conclusions:
- HPBD is a safe and effective first-line treatment for symptomatic pediatric POM.
- Further comparative studies are necessary to confirm long-term outcomes and treatment effects in infants.
- Identifying specific patient subgroups who will benefit most from HPBD remains a clinical challenge.
Objective:
We aimed to evaluate the effectiveness and complication rates of endoscopic high-pressure balloon dilatation (HPBD) in treating primary obstructive megaureter (POM) in children based on current literature. Specifically, we wanted to clarify the evidence on the use of HPBD in children under one year of age.
Methods:
A systematic search of the literature was performed via several databases. The preferred reporting items for systematic reviews and meta-analyses guidelines were followed. The primary outcomes studied in this systematic review were the effectiveness of HBPD in relieving obstruction and reducing hydroureteronephrosis in children. The secondary outcome was to study the complication rate of endoscopic high-pressure balloon dilatation. Studies that reported one or both of these outcomes (n = 13) were considered eligible for inclusion in this review.
Results:
HPBD significantly decreased both ureteral diameter (15.8 mm [range 2-30] to 8.0 mm [0-30], p = 0.00009) and anteroposterior diameter of renal pelvis (16.7 mm [0-46] to 9.7 mm [0-36], p = 0.00107). The success rate was 71% after one HPBD and 79% after two HPBD. The median follow-up time was 3.6 years (interquartile range 2.2-6.4 years). A complication rate of 33% was observed, but no Clavien-Dindo grade IV-V complications were reported. Postoperative infections and VUR were detected in 12% and 7.8% of cases, respectively. For children under one year of age, outcomes of HPBD seem to be similar to those in older children.
Conclusions:
This study indicates that HPBD appears to be safe and can be used as the first-line treatment for symptomatic POM. Further comparative studies are needed addressing the effect of treatment in infants, and also long-term outcomes of the treatment. Due to the nature of POM, identifying those patients who will benefit from HPBD remains challenging.
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urodynamic Studies: Uroflowmetry
Urinary Tract Calculi V: Nursing Management
Urologic Endoscopic Procedure: Cystoscopic Examination
Urinary Tract Calculi III: Medical Management

